Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Transactions
Holdings
All
13F
13D/G
Other
InvaGen Pharmaceuticals, Inc.
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
10/19/2022
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/13/2022
4
InvaGen Pharmaceuticals, Inc. (10% Owner) has filed a Form 4 on AVENUE THERAPEUTICS, INC.
Txns:
Sold 388,888 shares @ $7.714, valued at $3M
07/28/2022
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/31/2019
3
Form 3 - Initial statement of beneficial ownership of securities:
02/11/2019
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/23/2018
SC 13D
InvaGen Pharmaceuticals, Inc. reports a 38.6% stake in AVENUE THERAPEUTICS, INC.
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy